Marcus Buschbeck

20PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - amino acids and metabolitesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Dec 26, 2025
Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer.

Cristina Queralt, Cristina Moreta-Moraleda, Marta Costa

|Oct 24, 2025
Loss of histone macroH2A1.1 causes kidney abnormalities secondary to a change in nutrient metabolization.

René Winkler, Gemma Comas-Armangué, David Corujo

|Aug 12, 2025
Epigenetic control of topoisomerase 1 activity presents a cancer vulnerability.

Tae-Hee Lee, Colina X Qiao, Vladislav Kuzin

|Nov 01, 2024
Epigenetic control of Topoisomerase 1 activity presents a cancer vulnerability.

Tae-Hee Lee, Colina X Qiao, Vladislav Kuzin

|Aug 27, 2024
Histone variant macroH2A1 regulates synchronous firing of replication origins in the inactive X chromosome.

Maria Arroyo, Corella S Casas-Delucchi, Maruthi K Pabba

|Nov 21, 2023
regioneReloaded: evaluating the association of multiple genomic region sets.

Roberto Malinverni, David Corujo, Bernat Gel

Pageof 4